AI assistant
Sending…
LIGAND PHARMACEUTICALS INC — Director's Dealing 2011
Feb 17, 2011
31289_dirs_2011-02-17_f8dc952b-cd80-4fd8-97b3-f483f6540681.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2011-02-16
Reporting Person: Patel Sunil (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-16 | Common Stock | P | 200 | $9.18 | Acquired | 3533 | Direct |
| 2011-02-16 | Common Stock | P | 500 | $9.249 | Acquired | 4033 | Direct |
| 2011-02-16 | Common Stock | P | 5189 | $9.19 | Acquired | 9222 | Direct |
| 2011-02-16 | Common Stock | P | 411 | $9.249 | Acquired | 9633 | Direct |
| 2011-02-16 | Common Stock | P | 3700 | $9.25 | Acquired | 13333 | Direct |
More from LIGAND PHARMACEUTICALS INC
Proxy Solicitation & Information Statement
2026
May 18
M&A Activity
2026
May 18
Interim / Quarterly Report
2026
May 8
Earnings Release
2026
May 7
Major Shareholding Notification
2026
May 1
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 27
M&A Activity
2026
Apr 27
Annual Report
2026
Apr 21